Related Experiment Video
Updated: Jul 29, 2025
09:35
Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect
Published on: September 11, 2015
9.8K
Engineered combinatorial cell device for wound healing and bone regeneration.
Lucija Kadunc Polajnar1, Duško Lainšček1,2, Rok Gašperšič3
1Department of Synthetic Biology and Immunology, National Institute of Chemistry, Ljubljana, Slovenia.
Frontiers in Bioengineering and Biotechnology
|May 26, 2023
Summary
Engineered cells deliver combinations of growth factors for enhanced tissue regeneration. This combinatorial approach improves healing in wound and bone defect models, offering a safer alternative to stem cell therapy.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Tissue Engineering
Background:
- Growth factors are crucial for tissue repair, but combinations are key in stem cell therapy.
- Current stem cell therapies have potential risks and are labor-intensive.
- Mimicking natural healing with controlled growth factor release is desirable.
Purpose of the Study:
- To develop a "mix-and-match" combinatorial platform for growth factor delivery.
- To evaluate the efficacy of engineered cell-secreted growth factor combinations in tissue regeneration.
- To create a temporally controlled system for growth factor release during healing.
Main Methods:
- Engineered mammalian cell lines producing various growth factors were created.
- A "mix-and-match" combinatorial platform was utilized for factor selection.
- An in situ cell-based device was implemented for localized growth factor production in mouse and rat models.
- A genetic switch was introduced for temporal control of factor release.
Main Results:
- Combinations of engineered cell-secreted growth factors outperformed individual factors and stem cell-conditioned medium in a gap closure assay.
- The cell device improved cutaneous wound healing in mice.
- Significant bone regeneration was observed in rats with calvarial defects treated with the cell device.
- Systemic levels of secreted factors were negligible, confirming local therapeutic effects.
- Temporal control over factor release was achieved.
Conclusions:
- Engineered cell-based combinatorial growth factor therapy offers an efficient and potentially safer alternative to stem cell therapy for tissue regeneration.
- The developed platform allows for precise control over growth factor combinations and release timing.
- This approach holds promise for improving wound healing, bone regeneration, and potentially preventing scar formation.
